Peretto Giovanni, Gulletta Simone, Slavich Massimo, Campochiaro Corrado, Vignale Davide, De Luca Giacomo, Palmisano Anna, Villatore Andrea, Rizzo Stefania, Cavalli Giulio, De Gaspari Monica, Busnardo Elena, Gianolli Luigi, Dagna Lorenzo, Basso Cristina, Esposito Antonio, Sala Simone, Della Bella Paolo, Mazzone Patrizio
Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Myocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
J Pers Med. 2022 Oct 12;12(10):1702. doi: 10.3390/jpm12101702.
Background. Exercise stress test (EST) has been scarcely investigated in patients with arrhythmic myocarditis. Objectives. To report the results of EST late after myocarditis with arrhythmic vs. nonarrhythmic presentation. Methods. We enrolled consecutive adult patients with EST performed at least six months after acute myocarditis was diagnosed using gold-standard techniques. Patients with ventricular arrhythmia (VA) at presentation were compared with the nonarrhythmic group. Adverse events occurring during follow-up after EST included cardiac death, disease-related rehospitalization, malignant VA, and proven active myocarditis. Results. The study cohort was composed of 128 patients (age 41 ± 9 y, 70% males) undergoing EST after myocarditis. Of them, 64 (50%) had arrhythmic presentation. EST was performed after 15 ± 4 months from initial diagnosis, and was conducted on betablockers in 75 cases (59%). During EST, VA were more common in the arrhythmic group (43 vs. 4, p < 0.001), whereas signs and symptoms of ischemia were more prevalent in the nonarrhythmic one (6 vs. 1, p = 0.115). By 58-month mean follow-up, 52 patients (41%) experienced adverse events, with a greater prevalence among arrhythmic patients (39 vs. 13, p < 0.001). As documented both in the arrhythmic and nonarrhythmic subgroups, patients had greater prevalence of adverse events following a positive EST (40/54 vs. 12/74 with negative EST, p < 0.001). Electrocardiographic features of VA during EST correlated with the subsequent inflammatory restaging of myocarditis. Nonarrhythmic patients with uneventful EST both on- and off-treatment were free from subsequent adverse events. Conclusions. Late after the arrhythmic presentation of myocarditis, EST was frequently associated with recurrent VA. In both arrhythmic and nonarrhythmic myocarditis, EST abnormalities correlated with subsequent adverse outcomes.
背景。运动负荷试验(EST)在心律失常性心肌炎患者中鲜有研究。目的。报告心肌炎后出现心律失常与未出现心律失常表现时EST的晚期结果。方法。我们纳入了使用金标准技术确诊急性心肌炎后至少6个月进行EST的连续成年患者。将出现室性心律失常(VA)的患者与无心律失常组进行比较。EST后随访期间发生的不良事件包括心源性死亡、疾病相关再住院、恶性VA和确诊的活动性心肌炎。结果。研究队列由128例心肌炎后接受EST的患者组成(年龄41±9岁,70%为男性)。其中,64例(50%)出现心律失常表现。EST在初次诊断后15±4个月进行,75例(59%)患者在β受体阻滞剂治疗期间进行。EST期间,心律失常组VA更常见(43例对4例,p<0.001),而无心律失常组缺血的体征和症状更普遍(6例对1例,p=0.115)。平均随访58个月时,52例患者(41%)发生不良事件,心律失常患者中发生率更高(39例对13例,p<0.001)。如在心律失常和无心律失常亚组中均记录的那样,EST阳性患者不良事件发生率更高(EST阳性54例中有40例,EST阴性74例中有12例,p<0.001)。EST期间VA的心电图特征与心肌炎随后的炎症分期相关。EST期间及治疗期间均无异常的无心律失常患者无后续不良事件。结论。心肌炎出现心律失常表现后晚期,EST常与复发性VA相关。在心律失常性和无心律失常性心肌炎中,EST异常均与随后的不良结局相关。